If you wish to receive all of the company’s financial communications in real time, you can register directly by email at the following address: [email protected]
o Strong growth in H1 2022 revenue of +58%, at €4.1m (vs. H1 2021)
o 52% increase in gross margin achieved in the 1st half of 2022, standing at €2.6 million
o Lifting of the conditions precedent to the proposed capital increase with preferential subscription rights by issuing shares with equity warrants (ABSA), guaranteed up to €5.0 million by Sanyou Medical
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in spinal implants, announces its results for the first half of the current financial year, ended June 30, 2022 and approved by the Board of Directors on September 19, 2022.